Brief: Anika Therapeutics Q1 Revenue USD 26.168 Million

Anika Therapeutics

09/05/2025 12:06

May 09 (Reuters) - Anika Therapeutics Q1 net income USD -4.873 million.

Q1 income from operations USD -4.284 million

Q1 gross profit USD 14.681 million

Q1 pretax profit USD -3.869 million